| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterus | 87 | 2023 | 678 | 8.890 |
Why?
|
| Progesterone | 67 | 2024 | 513 | 7.100 |
Why?
|
| Receptors, Progesterone | 82 | 2024 | 1392 | 7.050 |
Why?
|
| Embryo Implantation | 50 | 2023 | 278 | 5.720 |
Why?
|
| Endometrium | 40 | 2024 | 470 | 5.670 |
Why?
|
| Decidua | 30 | 2024 | 154 | 4.250 |
Why?
|
| Mammary Glands, Animal | 25 | 2019 | 533 | 3.440 |
Why?
|
| RANK Ligand | 11 | 2022 | 119 | 3.390 |
Why?
|
| Nuclear Receptor Coactivator 2 | 12 | 2023 | 210 | 2.890 |
Why?
|
| Stromal Cells | 24 | 2024 | 825 | 2.530 |
Why?
|
| Morphogenesis | 12 | 2018 | 337 | 2.080 |
Why?
|
| Mice | 174 | 2024 | 34495 | 2.040 |
Why?
|
| Epithelial Cells | 31 | 2023 | 1818 | 1.980 |
Why?
|
| Animals | 188 | 2024 | 59536 | 1.660 |
Why?
|
| Early Growth Response Protein 1 | 3 | 2022 | 67 | 1.640 |
Why?
|
| Mice, Knockout | 80 | 2024 | 5710 | 1.630 |
Why?
|
| Endometriosis | 10 | 2024 | 214 | 1.590 |
Why?
|
| Transcriptome | 12 | 2022 | 1859 | 1.590 |
Why?
|
| Pregnancy | 74 | 2024 | 7573 | 1.560 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 3 | 2019 | 18 | 1.470 |
Why?
|
| Fertility | 18 | 2022 | 336 | 1.440 |
Why?
|
| Mice, Transgenic | 44 | 2022 | 4143 | 1.380 |
Why?
|
| CRISPR-Cas Systems | 3 | 2023 | 323 | 1.270 |
Why?
|
| Estrogens | 17 | 2024 | 751 | 1.240 |
Why?
|
| Doxycycline | 5 | 2022 | 178 | 1.200 |
Why?
|
| Signal Transduction | 54 | 2023 | 11965 | 1.100 |
Why?
|
| beta Catenin | 10 | 2021 | 688 | 1.090 |
Why?
|
| Transcription Factors | 12 | 2024 | 5270 | 1.050 |
Why?
|
| Gene Expression Regulation | 23 | 2021 | 4053 | 1.050 |
Why?
|
| Female | 180 | 2024 | 141928 | 1.040 |
Why?
|
| Estrogen Receptor alpha | 17 | 2023 | 701 | 1.030 |
Why?
|
| Mammary Glands, Human | 4 | 2007 | 184 | 0.970 |
Why?
|
| Transcription, Genetic | 9 | 2020 | 3154 | 0.960 |
Why?
|
| Epithelium | 16 | 2023 | 720 | 0.940 |
Why?
|
| Estradiol | 15 | 2023 | 748 | 0.890 |
Why?
|
| Salivary Gland Neoplasms | 2 | 2019 | 489 | 0.870 |
Why?
|
| Ovary | 15 | 2020 | 668 | 0.870 |
Why?
|
| Pregnancy, Animal | 4 | 2017 | 92 | 0.860 |
Why?
|
| Endometrial Neoplasms | 12 | 2023 | 1341 | 0.860 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2017 | 830 | 0.830 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 925 | 0.830 |
Why?
|
| Gene Expression Regulation, Developmental | 13 | 2021 | 1498 | 0.810 |
Why?
|
| Mice, Inbred C57BL | 40 | 2021 | 6942 | 0.780 |
Why?
|
| Infertility, Female | 13 | 2018 | 217 | 0.780 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 3 | 2022 | 46 | 0.760 |
Why?
|
| Genetic Engineering | 4 | 2018 | 288 | 0.750 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2010 | 221 | 0.730 |
Why?
|
| Nuclear Receptor Coactivators | 3 | 2015 | 76 | 0.710 |
Why?
|
| Progestins | 5 | 2016 | 87 | 0.700 |
Why?
|
| Cell Proliferation | 30 | 2020 | 7226 | 0.690 |
Why?
|
| PTEN Phosphohydrolase | 8 | 2020 | 986 | 0.680 |
Why?
|
| Infertility | 2 | 2018 | 123 | 0.680 |
Why?
|
| Salivary Glands | 1 | 2019 | 130 | 0.680 |
Why?
|
| Reproduction | 5 | 2021 | 253 | 0.650 |
Why?
|
| Repressor Proteins | 6 | 2020 | 1664 | 0.610 |
Why?
|
| Membrane Proteins | 6 | 2018 | 2819 | 0.590 |
Why?
|
| Ovulation | 5 | 2022 | 107 | 0.560 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2017 | 123 | 0.560 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2022 | 494 | 0.560 |
Why?
|
| Mifepristone | 8 | 2023 | 147 | 0.530 |
Why?
|
| Genes, Reporter | 2 | 2017 | 798 | 0.520 |
Why?
|
| Leukemia | 1 | 2024 | 1635 | 0.520 |
Why?
|
| Uterine Diseases | 2 | 2014 | 40 | 0.520 |
Why?
|
| Cell Differentiation | 19 | 2020 | 4078 | 0.510 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2016 | 270 | 0.510 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 3 | 2022 | 245 | 0.500 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2020 | 8873 | 0.480 |
Why?
|
| Integrases | 6 | 2021 | 262 | 0.480 |
Why?
|
| Neoplasm Proteins | 3 | 2024 | 3230 | 0.470 |
Why?
|
| Fallopian Tubes | 3 | 2021 | 119 | 0.470 |
Why?
|
| Models, Animal | 5 | 2018 | 664 | 0.460 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 8 | 2022 | 1265 | 0.460 |
Why?
|
| Wnt Proteins | 9 | 2017 | 397 | 0.450 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 622 | 0.440 |
Why?
|
| Cells, Cultured | 13 | 2020 | 5637 | 0.430 |
Why?
|
| Forkhead Box Protein O1 | 4 | 2020 | 167 | 0.410 |
Why?
|
| Gene Deletion | 14 | 2022 | 1442 | 0.410 |
Why?
|
| Humans | 82 | 2024 | 261506 | 0.400 |
Why?
|
| Abortion, Spontaneous | 3 | 2021 | 112 | 0.400 |
Why?
|
| Breast | 4 | 2020 | 1344 | 0.400 |
Why?
|
| Urogenital Abnormalities | 3 | 2020 | 174 | 0.390 |
Why?
|
| Carcinogenesis | 5 | 2023 | 1026 | 0.370 |
Why?
|
| Breast Neoplasms | 11 | 2020 | 15694 | 0.370 |
Why?
|
| Autophagy-Related Proteins | 2 | 2020 | 57 | 0.370 |
Why?
|
| Receptors, Steroid | 3 | 2024 | 286 | 0.360 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 3343 | 0.350 |
Why?
|
| Gene Expression Profiling | 9 | 2021 | 5159 | 0.350 |
Why?
|
| Estrous Cycle | 4 | 2020 | 37 | 0.350 |
Why?
|
| Disease Models, Animal | 13 | 2022 | 7222 | 0.340 |
Why?
|
| Stem Cells | 4 | 2023 | 1213 | 0.340 |
Why?
|
| Cell Nucleus | 3 | 2018 | 1620 | 0.340 |
Why?
|
| GATA2 Transcription Factor | 4 | 2018 | 68 | 0.340 |
Why?
|
| Nuclear Receptor Coactivator 3 | 2 | 2010 | 383 | 0.330 |
Why?
|
| Embryonic Development | 4 | 2020 | 306 | 0.330 |
Why?
|
| Cell Movement | 4 | 2022 | 2466 | 0.320 |
Why?
|
| Protein Isoforms | 6 | 2022 | 842 | 0.310 |
Why?
|
| Models, Genetic | 4 | 2010 | 1113 | 0.310 |
Why?
|
| Oviducts | 3 | 2021 | 149 | 0.300 |
Why?
|
| Tetracycline | 1 | 2007 | 90 | 0.300 |
Why?
|
| Precancerous Conditions | 3 | 2022 | 1058 | 0.300 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2021 | 630 | 0.300 |
Why?
|
| Endometrial Hyperplasia | 4 | 2019 | 112 | 0.300 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2014 | 2359 | 0.290 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2006 | 129 | 0.290 |
Why?
|
| Models, Biological | 11 | 2020 | 3254 | 0.280 |
Why?
|
| Gene Targeting | 3 | 2016 | 292 | 0.280 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2019 | 192 | 0.280 |
Why?
|
| Transforming Growth Factor beta | 4 | 2020 | 1130 | 0.280 |
Why?
|
| HMGB Proteins | 2 | 2018 | 16 | 0.280 |
Why?
|
| SOXF Transcription Factors | 2 | 2018 | 34 | 0.270 |
Why?
|
| Receptors, Transforming Growth Factor beta | 3 | 2017 | 229 | 0.270 |
Why?
|
| Wnt Signaling Pathway | 5 | 2021 | 430 | 0.270 |
Why?
|
| Ribonuclease III | 2 | 2020 | 182 | 0.270 |
Why?
|
| Luteinizing Hormone | 4 | 2020 | 165 | 0.270 |
Why?
|
| Receptors, Estrogen | 6 | 2022 | 2086 | 0.270 |
Why?
|
| Mice, Mutant Strains | 7 | 2021 | 634 | 0.270 |
Why?
|
| Autophagy | 3 | 2023 | 927 | 0.270 |
Why?
|
| Hedgehog Proteins | 7 | 2018 | 424 | 0.270 |
Why?
|
| Embryo, Mammalian | 6 | 2022 | 741 | 0.270 |
Why?
|
| COUP Transcription Factor II | 5 | 2023 | 126 | 0.260 |
Why?
|
| Immunohistochemistry | 15 | 2016 | 7548 | 0.260 |
Why?
|
| Cervix Uteri | 3 | 2016 | 253 | 0.260 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2020 | 255 | 0.260 |
Why?
|
| Placenta | 5 | 2016 | 516 | 0.260 |
Why?
|
| Trans-Activators | 5 | 2023 | 1555 | 0.250 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 3 | 2018 | 40 | 0.250 |
Why?
|
| Myometrium | 3 | 2019 | 79 | 0.250 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2023 | 973 | 0.250 |
Why?
|
| Thymus Gland | 2 | 2022 | 294 | 0.250 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2003 | 342 | 0.250 |
Why?
|
| STAT5 Transcription Factor | 2 | 2017 | 214 | 0.240 |
Why?
|
| Chromatin Immunoprecipitation | 5 | 2013 | 518 | 0.240 |
Why?
|
| Mice, Inbred BALB C | 6 | 2019 | 2314 | 0.240 |
Why?
|
| Cell Lineage | 1 | 2006 | 668 | 0.240 |
Why?
|
| Corpus Luteum | 4 | 2017 | 32 | 0.240 |
Why?
|
| Ovarian Follicle | 4 | 2020 | 152 | 0.240 |
Why?
|
| Gene Expression | 10 | 2020 | 3570 | 0.240 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 716 | 0.230 |
Why?
|
| Zinc Fingers | 1 | 2024 | 205 | 0.230 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 2 | 2020 | 13 | 0.230 |
Why?
|
| Granulosa Cells | 5 | 2022 | 146 | 0.230 |
Why?
|
| Vagina | 2 | 2016 | 317 | 0.220 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2022 | 1439 | 0.220 |
Why?
|
| Gene Knockout Techniques | 3 | 2020 | 276 | 0.220 |
Why?
|
| Versicans | 1 | 2022 | 28 | 0.220 |
Why?
|
| Agglutinins | 1 | 2022 | 19 | 0.220 |
Why?
|
| Paracrine Communication | 3 | 2013 | 128 | 0.220 |
Why?
|
| Keratin-5 | 1 | 2022 | 57 | 0.220 |
Why?
|
| Transcriptional Activation | 2 | 2019 | 1070 | 0.220 |
Why?
|
| RNA-Binding Proteins | 2 | 2021 | 984 | 0.220 |
Why?
|
| Receptors, Leptin | 1 | 2022 | 62 | 0.210 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2015 | 2508 | 0.210 |
Why?
|
| Embryonic Stem Cells | 2 | 2018 | 301 | 0.210 |
Why?
|
| Carcinoma, Endometrioid | 2 | 2016 | 323 | 0.210 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2021 | 54 | 0.200 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2019 | 673 | 0.200 |
Why?
|
| Parturition | 3 | 2022 | 65 | 0.200 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 1077 | 0.200 |
Why?
|
| TRPC Cation Channels | 1 | 2021 | 16 | 0.200 |
Why?
|
| Uterine Contraction | 1 | 2021 | 31 | 0.200 |
Why?
|
| Receptors, Oxytocin | 1 | 2021 | 23 | 0.200 |
Why?
|
| Placentation | 2 | 2012 | 60 | 0.200 |
Why?
|
| Forkhead Transcription Factors | 3 | 2022 | 778 | 0.200 |
Why?
|
| Alleles | 4 | 2023 | 2437 | 0.190 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2020 | 17 | 0.190 |
Why?
|
| Root Caries | 1 | 2020 | 1 | 0.190 |
Why?
|
| Ligands | 2 | 2022 | 995 | 0.190 |
Why?
|
| Phenotype | 6 | 2022 | 6295 | 0.190 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 170 | 0.190 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 17 | 0.190 |
Why?
|
| DNA-Binding Proteins | 4 | 2021 | 4821 | 0.190 |
Why?
|
| Protein Phosphatase 2 | 1 | 2020 | 88 | 0.190 |
Why?
|
| Gonadotrophs | 1 | 2020 | 3 | 0.190 |
Why?
|
| Exons | 2 | 2023 | 1328 | 0.190 |
Why?
|
| Cell Line | 8 | 2020 | 5114 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2020 | 2054 | 0.180 |
Why?
|
| RNA Interference | 4 | 2020 | 1408 | 0.180 |
Why?
|
| Vaginal Neoplasms | 1 | 2021 | 152 | 0.180 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2021 | 324 | 0.180 |
Why?
|
| Cell Division | 4 | 2011 | 2489 | 0.180 |
Why?
|
| Pregnancy Complications | 2 | 2015 | 526 | 0.180 |
Why?
|
| Cell Cycle Proteins | 3 | 2020 | 2045 | 0.170 |
Why?
|
| Lactation | 2 | 2011 | 210 | 0.170 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2020 | 178 | 0.170 |
Why?
|
| Chromatin | 2 | 2023 | 942 | 0.170 |
Why?
|
| Hormones | 1 | 2020 | 266 | 0.170 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 467 | 0.170 |
Why?
|
| Hindlimb | 1 | 2019 | 105 | 0.170 |
Why?
|
| Aldose-Ketose Isomerases | 1 | 2018 | 14 | 0.170 |
Why?
|
| Fetal Development | 2 | 2022 | 120 | 0.170 |
Why?
|
| Disease Progression | 7 | 2021 | 6682 | 0.160 |
Why?
|
| Fetal Growth Retardation | 3 | 2015 | 194 | 0.160 |
Why?
|
| Premature Birth | 2 | 2014 | 407 | 0.160 |
Why?
|
| Skin Diseases | 1 | 2021 | 349 | 0.160 |
Why?
|
| Ovarian Neoplasms | 3 | 2020 | 4638 | 0.160 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 69 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2018 | 32 | 0.160 |
Why?
|
| Bone Morphogenetic Protein 2 | 3 | 2014 | 142 | 0.160 |
Why?
|
| Cell Line, Tumor | 10 | 2022 | 14551 | 0.160 |
Why?
|
| Body Patterning | 1 | 2019 | 212 | 0.160 |
Why?
|
| NF-kappa B | 2 | 2022 | 1549 | 0.160 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2019 | 212 | 0.160 |
Why?
|
| Corpus Luteum Maintenance | 1 | 2017 | 3 | 0.160 |
Why?
|
| Luteal Cells | 1 | 2017 | 10 | 0.150 |
Why?
|
| BRCA1 Protein | 1 | 2020 | 493 | 0.150 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 470 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2017 | 3639 | 0.150 |
Why?
|
| RNA, Small Interfering | 4 | 2018 | 2216 | 0.150 |
Why?
|
| Luminescence | 1 | 2017 | 44 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 59 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 3 | 2020 | 769 | 0.150 |
Why?
|
| Male | 34 | 2021 | 123000 | 0.150 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2017 | 79 | 0.150 |
Why?
|
| Carbon Isotopes | 2 | 2018 | 333 | 0.150 |
Why?
|
| Cell Adhesion | 2 | 2017 | 1008 | 0.150 |
Why?
|
| Phosphorylation | 8 | 2020 | 4804 | 0.150 |
Why?
|
| Catecholamines | 1 | 2017 | 101 | 0.150 |
Why?
|
| RNA, Messenger | 9 | 2023 | 6150 | 0.150 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2017 | 122 | 0.150 |
Why?
|
| Isoproterenol | 1 | 2017 | 127 | 0.150 |
Why?
|
| Ovariectomy | 6 | 2013 | 330 | 0.150 |
Why?
|
| Kisspeptins | 1 | 2016 | 15 | 0.150 |
Why?
|
| Carcinoma | 3 | 2020 | 2578 | 0.140 |
Why?
|
| Homeostasis | 2 | 2020 | 950 | 0.140 |
Why?
|
| Computational Biology | 2 | 2018 | 1271 | 0.140 |
Why?
|
| GATA Transcription Factors | 1 | 2016 | 19 | 0.140 |
Why?
|
| Cdh1 Proteins | 2 | 2013 | 18 | 0.140 |
Why?
|
| Junctional Adhesion Molecule B | 1 | 2016 | 2 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2016 | 1823 | 0.140 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 677 | 0.140 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2020 | 486 | 0.140 |
Why?
|
| Mammals | 3 | 2022 | 361 | 0.140 |
Why?
|
| Janus Kinase 1 | 1 | 2017 | 121 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 703 | 0.140 |
Why?
|
| Receptors, Androgen | 2 | 2016 | 878 | 0.140 |
Why?
|
| Luteinization | 1 | 2015 | 13 | 0.140 |
Why?
|
| GATA6 Transcription Factor | 1 | 2015 | 23 | 0.140 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2015 | 74 | 0.140 |
Why?
|
| Crosses, Genetic | 3 | 2014 | 241 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2021 | 1331 | 0.140 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2016 | 87 | 0.140 |
Why?
|
| GATA4 Transcription Factor | 1 | 2015 | 45 | 0.130 |
Why?
|
| Menstruation | 1 | 2015 | 39 | 0.130 |
Why?
|
| Sexual Behavior, Animal | 2 | 2006 | 65 | 0.130 |
Why?
|
| Placental Insufficiency | 1 | 2015 | 7 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 6 | 2020 | 3101 | 0.130 |
Why?
|
| Homozygote | 4 | 2012 | 717 | 0.130 |
Why?
|
| Tamoxifen | 2 | 2017 | 876 | 0.130 |
Why?
|
| RNA Splicing Factors | 1 | 2016 | 153 | 0.130 |
Why?
|
| Animals, Newborn | 4 | 2015 | 1338 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2019 | 619 | 0.130 |
Why?
|
| alpha-Galactosidase | 1 | 2014 | 14 | 0.130 |
Why?
|
| Fabry Disease | 1 | 2014 | 15 | 0.130 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 550 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 651 | 0.130 |
Why?
|
| Vaginosis, Bacterial | 1 | 2014 | 22 | 0.130 |
Why?
|
| Heme Oxygenase-1 | 1 | 2015 | 54 | 0.130 |
Why?
|
| Estrogen Receptor beta | 1 | 2015 | 155 | 0.130 |
Why?
|
| Genitalia, Female | 1 | 2015 | 68 | 0.130 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2014 | 20 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2021 | 5437 | 0.120 |
Why?
|
| Protein Binding | 7 | 2017 | 3438 | 0.120 |
Why?
|
| Blotting, Western | 5 | 2017 | 3536 | 0.120 |
Why?
|
| Microarray Analysis | 2 | 2013 | 392 | 0.120 |
Why?
|
| Metaplasia | 1 | 2016 | 383 | 0.120 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2014 | 29 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2019 | 488 | 0.120 |
Why?
|
| src-Family Kinases | 1 | 2017 | 478 | 0.120 |
Why?
|
| Metabolic Flux Analysis | 1 | 2013 | 27 | 0.120 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2017 | 461 | 0.120 |
Why?
|
| Germ Cells | 1 | 2016 | 335 | 0.120 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 236 | 0.120 |
Why?
|
| Nuclear Receptor Coactivator 1 | 2 | 2012 | 236 | 0.120 |
Why?
|
| Ovarian Diseases | 1 | 2014 | 54 | 0.120 |
Why?
|
| Apoptosis | 12 | 2016 | 7591 | 0.120 |
Why?
|
| Activin Receptors, Type I | 1 | 2013 | 50 | 0.120 |
Why?
|
| Seminiferous Tubules | 1 | 2013 | 52 | 0.120 |
Why?
|
| Adenomyosis | 1 | 2013 | 11 | 0.120 |
Why?
|
| Receptor, Notch1 | 2 | 2013 | 218 | 0.120 |
Why?
|
| Phosphofructokinase-2 | 1 | 2013 | 38 | 0.120 |
Why?
|
| Inflammasomes | 1 | 2015 | 161 | 0.120 |
Why?
|
| Pregnancy Maintenance | 1 | 2013 | 5 | 0.120 |
Why?
|
| Isotope Labeling | 1 | 2013 | 142 | 0.120 |
Why?
|
| Prolactin | 4 | 2017 | 155 | 0.120 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2013 | 19 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2014 | 96 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 2 | 2013 | 345 | 0.110 |
Why?
|
| Medroxyprogesterone Acetate | 2 | 2013 | 55 | 0.110 |
Why?
|
| Hyaluronic Acid | 1 | 2014 | 168 | 0.110 |
Why?
|
| Serine | 1 | 2014 | 388 | 0.110 |
Why?
|
| Cytokines | 1 | 2022 | 2809 | 0.110 |
Why?
|
| Multigene Family | 1 | 2014 | 425 | 0.110 |
Why?
|
| Mutation | 8 | 2023 | 15179 | 0.110 |
Why?
|
| Phosphates | 1 | 2013 | 187 | 0.110 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2020 | 268 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2014 | 330 | 0.110 |
Why?
|
| Nodal Protein | 1 | 2012 | 21 | 0.110 |
Why?
|
| Cell Communication | 3 | 2011 | 509 | 0.110 |
Why?
|
| Janus Kinase 2 | 1 | 2017 | 679 | 0.110 |
Why?
|
| MicroRNAs | 5 | 2021 | 2947 | 0.110 |
Why?
|
| Membrane Glycoproteins | 2 | 2016 | 1073 | 0.110 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 1215 | 0.110 |
Why?
|
| MSX1 Transcription Factor | 1 | 2011 | 15 | 0.110 |
Why?
|
| Pituitary Gland | 2 | 2020 | 150 | 0.110 |
Why?
|
| Tuberous Sclerosis | 1 | 2013 | 136 | 0.100 |
Why?
|
| beta-Galactosidase | 2 | 2011 | 211 | 0.100 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2011 | 45 | 0.100 |
Why?
|
| Cellular Reprogramming | 1 | 2013 | 189 | 0.100 |
Why?
|
| Receptors, Notch | 1 | 2014 | 383 | 0.100 |
Why?
|
| Frizzled Receptors | 1 | 2010 | 25 | 0.100 |
Why?
|
| Prostate | 1 | 2016 | 1088 | 0.100 |
Why?
|
| Chorionic Gonadotropin | 2 | 2015 | 130 | 0.100 |
Why?
|
| Spermatogenesis | 1 | 2013 | 308 | 0.100 |
Why?
|
| Testis | 2 | 2013 | 717 | 0.100 |
Why?
|
| Pseudopregnancy | 4 | 2012 | 14 | 0.090 |
Why?
|
| Wnt4 Protein | 3 | 2017 | 31 | 0.090 |
Why?
|
| Spermatozoa | 1 | 2013 | 315 | 0.090 |
Why?
|
| Mullerian Ducts | 1 | 2011 | 76 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 3 | 2017 | 3981 | 0.090 |
Why?
|
| Intestines | 1 | 2014 | 686 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2014 | 419 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2013 | 1533 | 0.090 |
Why?
|
| Dexamethasone | 1 | 2015 | 1450 | 0.090 |
Why?
|
| Mice, 129 Strain | 3 | 2017 | 170 | 0.090 |
Why?
|
| Cell Death | 3 | 2019 | 671 | 0.090 |
Why?
|
| Polycomb Repressive Complex 2 | 2 | 2022 | 160 | 0.090 |
Why?
|
| Recombination, Genetic | 3 | 2011 | 613 | 0.090 |
Why?
|
| Stem Cell Niche | 1 | 2010 | 94 | 0.090 |
Why?
|
| Biomarkers | 1 | 2021 | 5047 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 998 | 0.090 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 1143 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 1 | 2011 | 257 | 0.090 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2014 | 519 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 2016 | 2022 | 0.090 |
Why?
|
| Mesoderm | 1 | 2011 | 404 | 0.080 |
Why?
|
| Heterozygote | 3 | 2012 | 1020 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 591 | 0.080 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2008 | 23 | 0.080 |
Why?
|
| Uterine Neoplasms | 1 | 2013 | 545 | 0.080 |
Why?
|
| Transgenes | 2 | 2007 | 557 | 0.080 |
Why?
|
| Gap Junctions | 1 | 2008 | 43 | 0.080 |
Why?
|
| Neurons | 2 | 2016 | 2287 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2012 | 1217 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 611 | 0.080 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 423 | 0.080 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 176 | 0.080 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2007 | 52 | 0.080 |
Why?
|
| Biomarkers, Tumor | 3 | 2016 | 10331 | 0.080 |
Why?
|
| Up-Regulation | 3 | 2020 | 2450 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2015 | 1000 | 0.080 |
Why?
|
| Bone Development | 1 | 2008 | 83 | 0.080 |
Why?
|
| Papillomavirus E7 Proteins | 2 | 2020 | 64 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 189 | 0.080 |
Why?
|
| Metabolome | 3 | 2018 | 344 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2022 | 3552 | 0.080 |
Why?
|
| Protein Transport | 2 | 2006 | 734 | 0.080 |
Why?
|
| Bone Remodeling | 1 | 2008 | 104 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 1586 | 0.080 |
Why?
|
| Organ Specificity | 3 | 2016 | 699 | 0.080 |
Why?
|
| DNA Primers | 2 | 2006 | 1399 | 0.070 |
Why?
|
| Gene Components | 1 | 2006 | 16 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2010 | 2084 | 0.070 |
Why?
|
| Organogenesis | 2 | 2018 | 119 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2008 | 229 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 3 | 2020 | 483 | 0.070 |
Why?
|
| Genes, ras | 1 | 2009 | 667 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 1121 | 0.070 |
Why?
|
| Substantia Nigra | 1 | 2006 | 41 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2013 | 1547 | 0.070 |
Why?
|
| Trophoblasts | 2 | 2020 | 138 | 0.070 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2006 | 81 | 0.070 |
Why?
|
| Ventral Tegmental Area | 1 | 2006 | 49 | 0.070 |
Why?
|
| Leukemia Inhibitory Factor | 2 | 2018 | 39 | 0.070 |
Why?
|
| Embryo Loss | 2 | 2017 | 42 | 0.070 |
Why?
|
| Kidney | 1 | 2014 | 2146 | 0.070 |
Why?
|
| Time Factors | 6 | 2017 | 12926 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2014 | 2295 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 1546 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 459 | 0.060 |
Why?
|
| Gonadotropins | 2 | 2020 | 50 | 0.060 |
Why?
|
| Lac Operon | 1 | 2005 | 122 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2020 | 460 | 0.060 |
Why?
|
| Cell Polarity | 2 | 2018 | 208 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 650 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2005 | 130 | 0.060 |
Why?
|
| Neoplasms, Experimental | 2 | 2020 | 750 | 0.060 |
Why?
|
| Serpins | 1 | 2004 | 77 | 0.060 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2016 | 167 | 0.060 |
Why?
|
| Down-Regulation | 3 | 2017 | 2074 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 2 | 2020 | 848 | 0.060 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2020 | 241 | 0.060 |
Why?
|
| Pregnancy Outcome | 2 | 2021 | 643 | 0.060 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2023 | 37 | 0.060 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2023 | 83 | 0.060 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2023 | 32 | 0.060 |
Why?
|
| Stroke | 1 | 2012 | 1144 | 0.060 |
Why?
|
| Glycolysis | 2 | 2018 | 519 | 0.060 |
Why?
|
| Beclin-1 | 1 | 2023 | 85 | 0.060 |
Why?
|
| Adherens Junctions | 2 | 2013 | 20 | 0.060 |
Why?
|
| Rodentia | 1 | 2023 | 65 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2016 | 110 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2021 | 1682 | 0.050 |
Why?
|
| Dilatation | 1 | 2022 | 83 | 0.050 |
Why?
|
| Macrophages | 2 | 2020 | 1304 | 0.050 |
Why?
|
| Horses | 1 | 2022 | 96 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2013 | 1833 | 0.050 |
Why?
|
| Parity | 1 | 2002 | 139 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 356 | 0.050 |
Why?
|
| In Situ Hybridization | 3 | 2010 | 1037 | 0.050 |
Why?
|
| Gene Silencing | 2 | 2016 | 837 | 0.050 |
Why?
|
| Arteries | 1 | 2022 | 274 | 0.050 |
Why?
|
| Lim Kinases | 1 | 2020 | 16 | 0.050 |
Why?
|
| Base Sequence | 3 | 2016 | 4917 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2020 | 17 | 0.050 |
Why?
|
| Salpingo-oophorectomy | 1 | 2020 | 50 | 0.050 |
Why?
|
| Aggression | 1 | 2003 | 252 | 0.050 |
Why?
|
| Genotype | 4 | 2014 | 4109 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 4 | 2009 | 3203 | 0.050 |
Why?
|
| Ectoderm | 1 | 2020 | 69 | 0.050 |
Why?
|
| Pregnancy, Tubal | 1 | 2020 | 13 | 0.050 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2020 | 72 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5178 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2020 | 86 | 0.050 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2020 | 133 | 0.040 |
Why?
|
| Sperm Count | 2 | 2013 | 100 | 0.040 |
Why?
|
| Aquaporins | 1 | 2019 | 23 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2003 | 709 | 0.040 |
Why?
|
| Transplantation Tolerance | 1 | 2019 | 15 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2014 | 1489 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 5767 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2014 | 1618 | 0.040 |
Why?
|
| Phosphoproteins | 2 | 2016 | 1152 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2019 | 90 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2015 | 1538 | 0.040 |
Why?
|
| Fibrosis | 1 | 2021 | 793 | 0.040 |
Why?
|
| Keratins | 1 | 2019 | 330 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 187 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2023 | 1152 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 29 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 2992 | 0.040 |
Why?
|
| Binding Sites | 2 | 2012 | 2171 | 0.040 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2017 | 87 | 0.040 |
Why?
|
| EGF Family of Proteins | 1 | 2017 | 28 | 0.040 |
Why?
|
| Receptors, OSM-LIF | 1 | 2017 | 12 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2019 | 242 | 0.040 |
Why?
|
| Aging, Premature | 1 | 2017 | 38 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 253 | 0.040 |
Why?
|
| Hypothalamus, Anterior | 1 | 2016 | 1 | 0.040 |
Why?
|
| Papillomaviridae | 1 | 2020 | 624 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 208 | 0.040 |
Why?
|
| Proteome | 1 | 2020 | 561 | 0.040 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2016 | 61 | 0.040 |
Why?
|
| Chorion | 1 | 2016 | 18 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2016 | 65 | 0.040 |
Why?
|
| Histone Acetyltransferases | 2 | 2009 | 411 | 0.030 |
Why?
|
| Skin | 1 | 2021 | 1259 | 0.030 |
Why?
|
| Chemokines | 1 | 2017 | 314 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 1399 | 0.030 |
Why?
|
| Proteins | 1 | 2004 | 1963 | 0.030 |
Why?
|
| Immunologic Surveillance | 1 | 2015 | 60 | 0.030 |
Why?
|
| Blastocyst | 1 | 2015 | 124 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2015 | 110 | 0.030 |
Why?
|
| Placental Circulation | 1 | 2015 | 17 | 0.030 |
Why?
|
| Noise | 1 | 2015 | 29 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2016 | 469 | 0.030 |
Why?
|
| Cell Survival | 2 | 2014 | 3045 | 0.030 |
Why?
|
| Organ Size | 2 | 2008 | 690 | 0.030 |
Why?
|
| Cysts | 1 | 2016 | 197 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 11538 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 703 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2017 | 1213 | 0.030 |
Why?
|
| Smad4 Protein | 1 | 2015 | 196 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2014 | 89 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 663 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 777 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 300 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2014 | 110 | 0.030 |
Why?
|
| Testosterone | 2 | 2013 | 619 | 0.030 |
Why?
|
| Tight Junction Proteins | 1 | 2013 | 13 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2010 | 2307 | 0.030 |
Why?
|
| Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2013 | 18 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 1688 | 0.030 |
Why?
|
| Receptor, ErbB-3 | 1 | 2014 | 122 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 81 | 0.030 |
Why?
|
| Activins | 1 | 2013 | 98 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 1 | 2014 | 143 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2013 | 62 | 0.030 |
Why?
|
| Aromatase | 1 | 2013 | 56 | 0.030 |
Why?
|
| Contraceptives, Oral, Synthetic | 1 | 2013 | 6 | 0.030 |
Why?
|
| Sexual Maturation | 1 | 2013 | 65 | 0.030 |
Why?
|
| Oocytes | 1 | 2016 | 414 | 0.030 |
Why?
|
| Leydig Cells | 1 | 2013 | 39 | 0.030 |
Why?
|
| Angiopoietins | 1 | 2013 | 35 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 503 | 0.030 |
Why?
|
| Genes, APC | 1 | 2013 | 70 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2014 | 145 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2014 | 146 | 0.030 |
Why?
|
| Giant Cells | 1 | 2013 | 69 | 0.030 |
Why?
|
| Injections | 1 | 2013 | 285 | 0.030 |
Why?
|
| Levonorgestrel | 1 | 2013 | 49 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 342 | 0.030 |
Why?
|
| Norprogesterones | 1 | 2012 | 2 | 0.030 |
Why?
|
| Pregnanolone | 1 | 2012 | 7 | 0.030 |
Why?
|
| Keratin-8 | 1 | 2012 | 19 | 0.030 |
Why?
|
| Occludin | 1 | 2012 | 31 | 0.030 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2012 | 30 | 0.030 |
Why?
|
| Promegestone | 1 | 2012 | 23 | 0.030 |
Why?
|
| alpha Catenin | 1 | 2012 | 23 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2013 | 202 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2014 | 221 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 342 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 2012 | 117 | 0.030 |
Why?
|
| Neprilysin | 1 | 2012 | 66 | 0.030 |
Why?
|
| Claudins | 1 | 2012 | 47 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2012 | 56 | 0.030 |
Why?
|
| Sertoli Cells | 1 | 2013 | 150 | 0.030 |
Why?
|
| Mucins | 1 | 2013 | 285 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 760 | 0.030 |
Why?
|
| Leiomyoma | 1 | 2013 | 145 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 2944 | 0.030 |
Why?
|
| Choristoma | 1 | 2012 | 85 | 0.030 |
Why?
|
| Fetal Death | 1 | 2012 | 113 | 0.030 |
Why?
|
| ADAMTS1 Protein | 1 | 2011 | 13 | 0.030 |
Why?
|
| Histones | 1 | 2019 | 1466 | 0.030 |
Why?
|
| Interleukin-15 | 1 | 2013 | 185 | 0.030 |
Why?
|
| Wnt-5a Protein | 1 | 2011 | 45 | 0.030 |
Why?
|
| Response Elements | 1 | 2012 | 193 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2013 | 275 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2012 | 448 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2012 | 629 | 0.030 |
Why?
|
| Cumulus Cells | 1 | 2011 | 44 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 702 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 201 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2012 | 256 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2017 | 1987 | 0.020 |
Why?
|
| Fetus | 1 | 2015 | 601 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 368 | 0.020 |
Why?
|
| Genes, Homeobox | 1 | 2011 | 147 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2013 | 602 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 2011 | 86 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 1062 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2011 | 98 | 0.020 |
Why?
|
| Aromatase Inhibitors | 1 | 2013 | 305 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 360 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2011 | 134 | 0.020 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2010 | 44 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2011 | 127 | 0.020 |
Why?
|
| Diethylstilbestrol | 1 | 2010 | 109 | 0.020 |
Why?
|
| Metabolomics | 1 | 2014 | 478 | 0.020 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2011 | 153 | 0.020 |
Why?
|
| Smoothened Receptor | 1 | 2010 | 52 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2011 | 267 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 2522 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2010 | 81 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 803 | 0.020 |
Why?
|
| Proteomics | 1 | 2017 | 1380 | 0.020 |
Why?
|
| Patched Receptors | 1 | 2009 | 46 | 0.020 |
Why?
|
| Patched-1 Receptor | 1 | 2009 | 48 | 0.020 |
Why?
|
| DNA Repair | 1 | 2017 | 1872 | 0.020 |
Why?
|
| Sirolimus | 1 | 2013 | 814 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 840 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 1081 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 264 | 0.020 |
Why?
|
| Connexin 43 | 1 | 2008 | 46 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 5395 | 0.020 |
Why?
|
| Epiphyses | 1 | 2008 | 13 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2013 | 769 | 0.020 |
Why?
|
| Genome | 1 | 2012 | 672 | 0.020 |
Why?
|
| Diaphyses | 1 | 2008 | 13 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2011 | 829 | 0.020 |
Why?
|
| Nitrobenzenes | 1 | 2008 | 30 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 2063 | 0.020 |
Why?
|
| Colforsin | 1 | 2008 | 59 | 0.020 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2007 | 21 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2008 | 74 | 0.020 |
Why?
|
| Litter Size | 1 | 2007 | 26 | 0.020 |
Why?
|
| Trefoil Factor-1 | 1 | 2007 | 15 | 0.020 |
Why?
|
| Humerus | 1 | 2008 | 53 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 334 | 0.020 |
Why?
|
| Indomethacin | 1 | 2008 | 91 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 854 | 0.020 |
Why?
|
| Embryo Implantation, Delayed | 1 | 2007 | 3 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 226 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 904 | 0.020 |
Why?
|
| Hormone Antagonists | 1 | 2008 | 101 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2008 | 154 | 0.020 |
Why?
|
| Tibia | 1 | 2008 | 131 | 0.020 |
Why?
|
| Dimerization | 1 | 2007 | 304 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2010 | 501 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2007 | 79 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2009 | 309 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2007 | 114 | 0.020 |
Why?
|
| Milk Proteins | 1 | 2007 | 116 | 0.020 |
Why?
|
| Ovulation Induction | 1 | 2007 | 62 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 1648 | 0.020 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2007 | 87 | 0.020 |
Why?
|
| Superovulation | 1 | 2006 | 14 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 2864 | 0.020 |
Why?
|
| Genetics, Behavioral | 1 | 2006 | 9 | 0.020 |
Why?
|
| Chimera | 1 | 2006 | 145 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 591 | 0.020 |
Why?
|
| Gestational Age | 1 | 2009 | 1069 | 0.020 |
Why?
|
| Dopamine Antagonists | 1 | 2006 | 52 | 0.020 |
Why?
|
| Electroporation | 1 | 2006 | 126 | 0.020 |
Why?
|
| Anilides | 1 | 2008 | 268 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 6100 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2005 | 191 | 0.020 |
Why?
|
| Retinoic Acid 4-Hydroxylase | 1 | 2005 | 18 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2006 | 79 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 862 | 0.020 |
Why?
|
| Enzymes | 1 | 2005 | 64 | 0.020 |
Why?
|
| Bone Density | 1 | 2008 | 476 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2015 | 2669 | 0.020 |
Why?
|
| Adult | 3 | 2020 | 77950 | 0.020 |
Why?
|
| Receptor, ErbB-2 | 1 | 2014 | 2518 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 2483 | 0.020 |
Why?
|
| Dopamine | 1 | 2006 | 312 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6207 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 6086 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 521 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2005 | 200 | 0.010 |
Why?
|
| Genes, p53 | 1 | 2008 | 1090 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 5539 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2006 | 417 | 0.010 |
Why?
|
| Body Weight | 1 | 2008 | 1293 | 0.010 |
Why?
|
| Castration | 1 | 2003 | 122 | 0.010 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2002 | 108 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 1491 | 0.010 |
Why?
|
| Aldosterone | 1 | 2002 | 72 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2002 | 241 | 0.010 |
Why?
|
| Aging | 1 | 2010 | 1582 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2002 | 388 | 0.010 |
Why?
|
| Motor Activity | 1 | 2005 | 693 | 0.010 |
Why?
|
| Adolescent | 2 | 2013 | 31252 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 1165 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 86204 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2004 | 1064 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 538 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 4938 | 0.010 |
Why?
|
| Brain | 1 | 2012 | 4113 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2008 | 1823 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 4757 | 0.010 |
Why?
|
| Age Factors | 1 | 2008 | 5377 | 0.010 |
Why?
|
| Anxiety | 1 | 2005 | 1179 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 2139 | 0.010 |
Why?
|
| Insulin | 1 | 2002 | 1454 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 21713 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 2693 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 21445 | 0.010 |
Why?
|